NCT07869719

Brief Summary

This randomized controlled trial aims to compare the efficacy and safety of nasal continuous positive airway pressure versus high-flow nasal cannula as initial non-invasive respiratory support in preterm infants with respiratory distress syndrome.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Oct 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

October 10, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2028

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

1 year

First QC Date

October 6, 2026

Last Update Submit

October 6, 2026

Conditions

Keywords

nCPAPHigh-flow nasal cannulaRespiratory distress syndromeNICUAssiutPreterm infants

Outcome Measures

Primary Outcomes (1)

  • Treatment failure within 72 hours

    Number of infants meeting predefined criteria for treatment failure of the assigned non-invasive respiratory support modality within the first 72 hours.

    At 72 hours

Secondary Outcomes (5)

  • Need for mechanical ventilation

    At 72 hours

  • Need for surfactant therapy

    At 72 hours

  • Duration of respiratory support

    At 28 days

  • Incidence of nasal trauma

    At 28 days

  • Incidence of pneumothorax

    At 28 days

Study Arms (2)

Nasal Continuous Positive Airway Pressure

EXPERIMENTAL

Preterm infants will receive nasal continuous positive airway pressure through an appropriate neonatal interface.

Device: Non-invasive respiratory support

High-Flow Nasal Cannula

ACTIVE COMPARATOR

Preterm infants will receive heated and humidified high-flow nasal cannula therapy.

Device: Non-invasive respiratory support

Interventions

Non-invasive respiratory support using either nCPAP or high-flow nasal cannula according to group allocation.

High-Flow Nasal CannulaNasal Continuous Positive Airway Pressure

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \- Preterm infants with gestational age 28 to 36 weeks and 6 days
  • Clinical diagnosis of respiratory distress syndrome
  • Spontaneous breathing without immediate need for invasive mechanical ventilation
  • Requirement for non-invasive respiratory support
  • Written informed consent from parent or legal guardian

You may not qualify if:

  • \- Infants requiring immediate endotracheal intubation and mechanical ventilation
  • Major congenital anomalies affecting the respiratory or cardiovascular systems
  • Congenital diaphragmatic hernia
  • Significant congenital heart disease
  • Severe perinatal asphyxia requiring prolonged resuscitation
  • Severe hemodynamic instability
  • Prolonged mechanical ventilation before enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Distress SyndromePremature Birth

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Hekma S Farghaly, prof

    Pediatrics Department, Assiut University Hospitals

    STUDY CHAIR

Central Study Contacts

Yara S Mahmoud, Resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician, Department of Pediatrics

Study Record Dates

First Submitted

October 6, 2026

First Posted

October 9, 2026

Study Start

October 10, 2026

Primary Completion (Estimated)

October 10, 2027

Study Completion (Estimated)

February 25, 2028

Last Updated

October 9, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share